1 big thing: Congress takes on PBMs

1 big thing: Congress takes on PBMs

“Alex Brill, CEO of the economic consulting firm Matrix Global Advisors and a senior fellow at AEI, said it is “unnecessary” to require PBMs to pass the rebates along to plans.”

The State of Biosimilars: What to Watch

The State of Biosimilars: What to Watch

Now that biosimilar versions of Humira are starting to arrive, what happens next? Will this finally prove the case that biosimilars can deliver on big health care savings?

A More Affordable Future Through Competition

A More Affordable Future Through Competition

“If Republicans take control of Congress in this fall’s election, protecting previously passed policies will be among the party’s top priority, said Alex Brill, a senior fellow at the American Enterprise Institute for Public Policy Research, a conservative think tank based in Washington, D.C. “